Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods

Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods

Triple-negative breast cancer (TNBC) poses a significant challenge in terms of prognosis and disease recurrence. The limited treatment options and the development of resistance to chemotherapy make it particularly difficult to manage these patients. However, recent research has been shifting its foc...

Full description

Bibliographic Details
Main Authors: Francesca Maria Porta, Elham Sajjadi, Konstantinos Venetis, Chiara Frascarelli, Giulia Cursano, Elena Guerini-Rocco, Nicola Fusco, Mariia Ivanova
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Journal of Personalized Medicine
Subjects:
breast cancer
TNBC
biomarkers
immune landscape
PD-L1
tumor-infiltrating lymphocytes
Online Access:https://www.mdpi.com/2075-4426/13/7/1176

Internet

https://www.mdpi.com/2075-4426/13/7/1176

Similar Items